Search for Clinical Trial Results

Lymphatic Malformations - 25 Studies Found
Status | Study |
Terminated |
Study Name: Selenium in the Treatment of Complicated Lymphatic Malformations Condition: Lymphatic Malformations Date: 2010-09-24 Interventions: Drug: Selenium 400 μg once a day for 6 months by mouth |
Completed |
Study Name: Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations Condition: Lymphatic Malformations Date: 2001-02-02 Interventions: Drug: picibanil Up to .2 mg per injection, given intralesionally every 6-8 weeks |
Completed |
Study Name: A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations Condition: Lymphangioma Date: 2011-02-03 Interventions: Drug: Sildenafil Sildenafil oral tablet three times daily |
Recruiting |
Study Name: Sildenafil for the Treatment of Lymphatic Malformations Condition:
Date: 2015-01-07 Interventions:
|
Active, not recruiting |
Study Name: Airway Vascular Lesions Condition:
|
Recruiting |
Study Name: Lymphatic Anomalies Registry Condition:
Date: 2015-03-17 |
Completed |
Study Name: Diagnosis of Hemangiomas and Vascular Malformations Condition:
|
Active, not recruiting |
Study Name: Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies Condition:
|
Completed |
Study Name: Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options. Condition: Vascular Anomalies Date: 2005-12-02 Interventions: Drug: Marimastat |
Completed |
Study Name: Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions Condition: 22q11.2 Deletion Syndrome Date: 2016-08-29 Interventions: Drug: NFC-1 Doses of NFC-1 will be administered as 50, 100, 200, or 400 mg twice daily as size 2, hard g |